ESC Professional Premium Access

Current issues in lipid-lowering therapy

Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session type: Moderated ePosters
Date: 27 August 2022
Time: 14:15 - 15:00

Congress Session

6 presentations in this session

Efficacy and safety of pemafibrate versus bezafibrate in coronary artery disease patients receiving statin treatment: a randomized, open-label, cross-over study

Speaker: Doctor A. Nakamura (Morioka, JP)
Thumbnail

LDL levels and long-term all-cause mortality in patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.

Speaker: Professor M. Banach (Lodz, PL)
Thumbnail

Preliminary results from REALITY: a nation-wide study of a database with 1.8 million real-life patients to study atherosclerotic cardiovascular disease and familial hypercholesterolemia in Spain

Speaker: Professor V. Barrios (Madrid, ES)
Thumbnail

Statin therapy in children with familial hypercholesterolemia: A meta-analysis.

Speaker: Doctor J. Lewek (Lodz, PL)
Thumbnail

Low-density lipoprotein cholesterol target attainment among statin-naive Chinese atherosclerotic vascular disease patients

Speaker: Ms H. Sun (Shatin, HK)
Thumbnail

High long-term persistence to evolocumab treatment regimens in European clinical practice: analysis of the HEYMANS registry

Speaker: Doctor M. Sibartie (Uxbridge, GB)
Thumbnail

6 speakers from this session

Doctor Akihiro Nakamura

Iwate Prefectural Central Hospital, Morioka (Japan)
0 follower

Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)
4 presentations
1 follower

Professor Vivencio Barrios

Ramon and Cajal University Hospital, Madrid (Spain)
1 presentation
0 follower

Doctor Joanna Lewek

Medical University of Lodz, Lodz (Poland)
1 presentation
0 follower

Ms Hui Sun

Prince of Wales Hospital, Shatin (Hong Kong)
0 follower

Doctor Mahendra Sibartie

Amgen, Uxbridge (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk